Extensively drug-resistant tuberculosis

N Engl J Med. 2008 Nov 27;359(22):2390; author reply 2391. doi: 10.1056/NEJMc081884.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Aza Compounds / therapeutic use*
  • Drug Therapy, Combination
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Fluoroquinolones
  • Humans
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Quinolines / therapeutic use*
  • South Africa
  • Treatment Outcome

Substances

  • Antitubercular Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin